Solvonis Therapeutics plc

SVNS.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-£0-£1-£2
Dep. & Amort.£0£0£0
Deferred Tax£0£0£0
Stock-Based Comp.£0£0£0
Change in WC£0£0-£0
Other Non-Cash£0£0£1
Operating Cash Flow-£0-£0-£0
Investing Activities
PP&E Inv.£0-£0£0
Net Acquisitions£0£0£0
Inv. Purchases£0-£0£0
Inv. Sales/Matur.£0£0£0
Other Inv. Act.-£0£0-£0
Investing Cash Flow-£0-£0£0
Financing Activities
Debt Repay.£0£0£0
Stock Issued£0£0£0
Stock Repurch.£0£0£0
Dividends Paid£0£0£0
Other Fin. Act.-£0£0£0
Financing Cash Flow£0£0£0
Forex Effect-£0£0-£0
Net Chg. in Cash-£0£0-£0
Supplemental Information
Beg. Cash£1£0£1
End Cash£1£0£0
Free Cash Flow-£0-£0-£0
Solvonis Therapeutics plc (SVNS.L) Financial Statements & Key Stats | AlphaPilot